ReachRxResearch
Home
Research
Sign Up
Estimating the incidence and duration of diagnostic delays for measles
Back to Research Hub
  1. Home
  2. Research Hub
  3. Estimating the incidence and duration of…

Estimating the incidence and duration of diagnostic delays for measles

Infection Control & Hospital Epidemiology·October 26
Infectious DiseasesSafety signalMeaslesCase-Crossover StudyDiagnostic TestingMixed

Summary

View source

What was studied

Using a case-crossover design with MarketScan claims data (2001–2023), this study estimated the incidence and duration of diagnostic delays for measles among 4,651 U.S. cases by examining healthcare encounters in the two weeks before confirmed diagnosis.

Key findings

About 6.9% (95% CI: 6.1–8.0%) of patients had at least one missed diagnostic opportunity, with a mean delay of 4.05 days (95% CI: 3.48–4.51); 1.7% experienced delays ≥1 week. Delays occurred most often in outpatient settings (81%), and age <2 years and antibiotic prescriptions were associated with higher likelihood of delay.

Study limitations

Claims data cannot confirm true clinical presentation or clinician reasoning, so 'missed opportunities' are inferred from billed diagnoses and symptoms rather than chart review. The MarketScan database skews toward commercially insured populations, potentially underrepresenting uninsured or Medicaid patients who may have different care-seeking patterns.

Clinical implications

Clinicians—especially in outpatient settings—should keep measles on the differential for febrile rash illness, particularly in children under 2 years, and resist anchoring on antibiotic-responsive conditions before ruling out measles. Early recognition shortens the infectious window and limits transmission.

Caveats

  • Missed diagnostic opportunities are defined algorithmically from claims codes for compatible signs and symptoms, not from clinical chart review, which may overestimate or underestimate true delays
  • The case-crossover design controls for within-person confounding but cannot fully account for evolving symptom presentation across the measles prodrome
  • The study population is drawn exclusively from commercially insured patients in the MarketScan database (2001–2023), which may not reflect the uninsured or publicly insured populations where measles burden is often higher

Related Questions

Explore related topics

What factors predict diagnostic delay for measles in outpatient settings?How does measles diagnostic delay contribute to community transmission risk?Best practices for early measles recognition and isolation in primary care

Publication Details

Year
2026
Journal
Infection Control &amp; Hospital Epidemiology
Sample Size
n=4,651
Source
View article
Keep scrolling
More content below.
Up Next